Your browser doesn't support javascript.
loading
Therapeutic management of a symptomatic Kaposi's sarcoma patient with renal failure undergoing haemodialysis: A case report.
Passarelli, Anna; Galdo, Giovanna; Pellegrino, Teresa; Roviello, Giandomenico; Aieta, Michele; Aviello, Gabriella; Conca, Raffaele.
Afiliación
  • Passarelli A; Unit of Medical Oncology, Department of Onco-Hematology, Centro di Riferimento Oncologico della Basilicata (IRCCS-CROB), Rionero in Vulture (PZ).
  • Galdo G; Department of Urology and Gynecology, Istituto Nazionale Tumori IRCCS Fondazione G. Pascale, Naples.
  • Pellegrino T; Oncologic Dermatology Unit, Department of Onco-Hematology, IRCCS-CROB, Centro di Riferimento Oncologico della Basilicata (IRCCSCROB), Rionero in Vulture (PZ).
  • Roviello G; Nuclear Medicine Department, Centro di Riferimento Oncologico della Basilicata (IRCCS-CROB), Rionero in Vulture (PZ).
  • Aieta M; Department of Health Sciences, University of Florence.
  • Aviello G; Unit of Medical Oncology, Department of Onco-Hematology, Centro di Riferimento Oncologico della Basilicata (IRCCS-CROB), Rionero in Vulture (PZ).
  • Conca R; Department of Pharmacy, School of Medicine and Surgery, University of Naples Federico II, Naples, Italy.
Dermatol Reports ; 14(1): 9113, 2022 Mar 11.
Article en En | MEDLINE | ID: mdl-35371419
ABSTRACT
Kaposi's sarcoma (KS) is a rare inflammation- based vascular cancer involving the skin. The viral aetiology of KS is the Human Herpesvirus 8. KS may be frequently diagnosed in immunosuppressed kidneytransplanted patients, while is less common in patients with dialysis. It is known that various immunological abnormalities can lead to impaired immune status in uremic patients. It is noteworthy that despite the incidence of KS in patients with renal impairment, only few cases have reported efficacy and safety profile of KS targeting anti-cancer drugs in this kidney disease population. Herein, we report the first case of a symptomatic KS patient with renal disease in haemodialysis and focus on its therapeutic management. We also review the main data available from literature regarding the safety of KS therapy in dialysis patients.
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Diagnostic_studies Idioma: En Revista: Dermatol Reports Año: 2022 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Diagnostic_studies Idioma: En Revista: Dermatol Reports Año: 2022 Tipo del documento: Article